mRNA medicines fight diseases in a different way than traditional medicine by prompting your immune system to create the tools to treat or prevent disease.
- CareersJoin Moderna as we pursue the uncharted reaches of possibility ...
- About usWe're making biotech history. Since 2010, we have worked to ...
- News and Blog PostsRead and download all Moderna-related news related to ...
- Moderna COVID-19 VaccineThis information is for residents of the United States ... Moderna ...
- The Power of mRNAAn mRNA can teach the body how to make a specific protein that ...
- Investor Relations OverviewOverview of Moderna news, events & presentations, latest quarterly ...
an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines.
The Moderna COVID-19 Vaccine (2024-2025 Formula) is authorized for all doses administered to individuals 6 months through 11 years of age to prevent COVID-19.
- 所在施設:
- 住所:東京都港区虎ノ門4丁目1番1号
- 最寄り駅:神谷町駅[4b]徒歩2分
Our mission is to deliver the greatest possible impact to people through mRNA medicines. Biotechnology Company Cambridge, MA modernatx.com Joined December 2013
Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally.
Moderna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made.
Moderna Inc. is a biotechnology company. The Company is advancing a new class of medicines made of messenger ribonucleic acid (mRNA).
モデルナ
モデルナ(Moderna [məˈdɜːrnə])は、アメリカ合衆国マサチューセッツ州ケンブリッジに本社を置くバイオテクノロジー企業。メッセ...Wikipedia
- 株価32.06ドル前日比+0.48ドル(+1.52%)
7月16日20時00分(現地時間) 現在ご注意 - 時価総額12,398,943千ドル
- 代表者Stéphane Bancel
- 本部所在地ケンブリッジ
- 設立2016年7月22日